Hypertension Case Finding

Written by AlisonFreemantle on Friday 27th August 2021

Advanced Service expected to start in October 2021 to support the NHS Long Term Plan ambitions for prevention of cardiovascular disease.

This service will have 2 stages

  1. Stage 1: Identifying people at risk of hypertension and offering them blood pressure monitoring (clinic check).
  2. Stage 2: Where clinically indicated, provide ambulatory blood pressure monitoring (ABPM). The blood pressure test results will then be shared with the patient’s GP to then inform a potential diagnosis of hypertension.

Fees

The fees for this service are as follows:

  • a set-up fee of £440
  • a fee for each clinic check of £15
  • a fee for each ambulatory monitoring of £45

Incentive

The incentive fees across years 3, 4 and 5 of CPCF for the service to encourage delivery of ABPM.

Pharmacies must reach a threshold of ABPMs provided to trigger the incentive payment.

  • Year 3 threshold 5, incentive payment £1,000 (21/22)
  • Year 4 threshold 15, incentive payment £400 (22/23)
  • Year 5 threshold 20, incentive payment £400 (23/24)

ABPM to be offered to patients who are clinically indicated (i.e. have had a high BP result as part of their clinical check).

Pharmacies who sign up after year 2021/22 must achieve the ABPM activity threshold specified for the given financial year and will receive £1,000 as a first payment. If a contractor signs up in year 3 and fails to do 5 ABPMs, they can earn £1,000 by doing 15 ABPMs in year 4.

The incentive payments will be funded separately by NHSE&I to incentivise case finding in line with the ambition outlined in the NHS Long Term Plan.

More detail can be found on the PSNC website:

Detail to follow:

How clinical checks will be recorded

Training requirements

Equipment requirements